Indicator | Total | n | % (95% CI) |
---|---|---|---|
Two-week morbidity prevalence (N = 1482) | |||
Any illness | 1479* | 637 | 43.1% (40.6–45.6) |
Gynaecological illness | 334a | 19 | 5.7% (3.6–8.8) |
Non-communicable disease prevalence among adults (N = 582) | |||
Any NCD | 582 | 165 | 28.4% (24.8–32.3) |
CVD | 582 | 29 | 5.0% (3.5–7.1) |
Hypertension | 582 | 28 | 4.8% (3.3–6.9) |
Disability | 582 | 25 | 4.3% (2.9–6.3) |
Asthma and other chronic respiratory conditions | 582 | 24 | 4.1% (2.8–6.1) |
Musculoskeletal disease (incl. arthritis) | 582 | 23 | 4.0% (2.6–5.9) |
Diabetes | 582 | 22 | 3.8% (2.5–5.7) |
Vaccination coverage in children aged 6–59 months (N = 263) | |||
One dose of BCG | 259* | 222 | 85.7% (80.9–89.5) |
Four doses of polio vaccine in children aged 24–59 months | 172b | 45 | 26.2% (20.1–33.3) |
Two doses of measles vaccine aged 24–59 months | 170b | 47 | 27.6% (21.4–34.9) |
Four doses of pentavalent vaccine aged 24–59 months | 172b | 35 | 20.3% (14.9–27.1) |
Full immunization for BCG, polio, measles and pentavalent aged 24–59 months | 170b | 24 | 14.1% (9.6–20.3). |
Malnutrition prevalence among children aged 6–59 months (N = 263) | |||
GAM | 249* | 9 | 3.6% (1.9–6.8) |
SAM | 249* | 0 | – |